Nivolumab Hetero contains Nivolumab, 40mg, 100mg vials, supplied as injection (iv). Manufacturer: Hetero Biopharma. Therapeutic class: PD-1 mAb Biosimilar.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.